Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway
Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is a paper indexed in PICO Portal from OpenAlex.
How many citations does Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway have?
Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway has 6 citations in the OpenAlex counts PICO Portal stores.
When was Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway published?
Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway has 2025 year in the PICO Portal index.
What is the open-access status of Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?
Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway has gold oa status in the PICO Portal index.
What is the DOI of Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?
The DOI for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is on the source record.
What is the PMID of Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?
The PMID for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is on the source record.
What is the OpenAlex record for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?
The OpenAlex for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is on the source record.